Free Trial

UBS Group Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $31.00

Acadia Healthcare logo with Medical background

Key Points

  • UBS Group has significantly reduced its price target for Acadia Healthcare from $45.00 to $31.00 while maintaining a "buy" rating, reflecting a potential upside of 69.87% from the current trading price.
  • Acadia Healthcare's stock increased by 1.4% to $18.25 amid a higher volume of trade, with a market cap of $1.68 billion and a P/E ratio of 12.12.
  • Analyst ratings for Acadia Healthcare show a consensus of "Moderate Buy," with five analysts rating it as a hold and seven issuing buy ratings, amidst price target adjustments from various firms.
  • Need Better Tools to Track Acadia Healthcare? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its target price dropped by research analysts at UBS Group from $45.00 to $31.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's target price indicates a potential upside of 69.87% from the company's current price.

Other analysts also recently issued reports about the company. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday. Guggenheim lowered their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a report on Thursday. KeyCorp dropped their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Barclays dropped their target price on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a report on Thursday. Finally, Stephens upgraded Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $44.75.

Get Our Latest Research Report on Acadia Healthcare

Acadia Healthcare Stock Up 1.4%

Acadia Healthcare stock traded up $0.25 during mid-day trading on Thursday, reaching $18.25. 1,960,446 shares of the company's stock were exchanged, compared to its average volume of 2,174,827. The company has a fifty day moving average of $22.34 and a 200-day moving average of $28.23. The company has a market cap of $1.68 billion, a P/E ratio of 12.12, a P/E/G ratio of 4.15 and a beta of 0.88. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72. Acadia Healthcare has a twelve month low of $17.13 and a twelve month high of $82.40.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.36% and a net margin of 4.31%. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same period in the previous year, the business earned $0.91 EPS. Acadia Healthcare's revenue for the quarter was up 9.2% on a year-over-year basis. Sell-side analysts expect that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 143.8% during the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock worth $176,000 after acquiring an additional 3,428 shares during the last quarter. Envestnet Portfolio Solutions Inc. bought a new stake in shares of Acadia Healthcare during the 1st quarter valued at $222,000. Sterling Capital Management LLC boosted its position in shares of Acadia Healthcare by 59.1% in the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after purchasing an additional 2,026 shares during the last quarter. Raiffeisen Bank International AG boosted its holdings in Acadia Healthcare by 33.3% during the first quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company's stock worth $4,819,000 after buying an additional 40,000 shares during the last quarter. Finally, Teacher Retirement System of Texas acquired a new position in shares of Acadia Healthcare during the 1st quarter worth about $412,000.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Further Reading

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines